Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Chem Biol Interact ; 303: 70-78, 2019 Apr 25.
Artigo em Inglês | MEDLINE | ID: mdl-30826251

RESUMO

Obesity has been implicated in the genesis of metabolic syndromes including insulin resistance and Type 2 Diabetes Mellitus (T2DM). Given the association between T2DM and the risk of hepatocellular carcinoma (HCC), our specific goal was to determine whether the liver of HFD-induced T2DM mice is more sensitive to the carcinogen diethylnitrosamine (DEN), due to a modification of the molecular pathways implicated in the early stages of HCC pathogenesis. C57BL/6 male mice (five-week-old) were divided into 4 groups: C, C + DEN, HFD and HFD + DEN. Mice were euthanized twenty-five weeks after DEN-injection. Livers of HDF-fed mice showed a higher proliferative index than Control groups. In line with this, HFD groups showed an increase of nuclear ß-catenin, and interestingly, DEN treatment led to a slight increase in the expression of this protein in HFD group. Based on these results, and to confirm this effect, we analyzed ß-catenin target genes, finding that DEN treatment in HFD group led to a significant increase of Vegf, c-myc, c-jun and cyclin D1 expression levels. According to our results, the expression of TCF4 showed to be significantly increased in HFD + DEN vs. HFD. In this regard, the ß-catenin/TCF4 complex enhanced its association with pSmads 2/3, as we observed an increase of nuclear Smads expression in HFD + DEN, suggesting a possible role of TGF-ß1/Smads signaling pathway in this phenomenon. Our results show that the liver of HFD fed model that resembles early T2DM pathology in mice, is more sensitive to DEN, by inducing both Wnt/ß-catenin and TGF ß1/Smads tumorigenic pathways.


Assuntos
Carcinogênese/genética , Dieta Hiperlipídica/efeitos adversos , Dietilnitrosamina/efeitos adversos , Neoplasias Hepáticas Experimentais/etiologia , Alquilantes/efeitos adversos , Animais , Carcinogênese/efeitos dos fármacos , Fígado/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Smad/metabolismo , Fator de Crescimento Transformador beta1/metabolismo , Via de Sinalização Wnt/efeitos dos fármacos
2.
Phys Chem Chem Phys ; 20(46): 29558-29565, 2018 Nov 28.
Artigo em Inglês | MEDLINE | ID: mdl-30457613

RESUMO

Gold nanoparticles (AuNPs) of differing shapes are of great interest to researchers due to their unique optical properties, making them potentially powerful theranostic tools. The synthesis of AuNPs is performed frequently, however the assessment of biological activity for each nanoparticle is not always commonplace. While it is thought that physicochemical parameters such as shape may play an important role in dictating the outcomes of interactions which take place at the nano-bio interface, a systematic approach to the assessment of nanomaterials has not been widely adopted. In this study, the interaction between human serum albumin (HSA) and four similar sized but different shaped AuNPs (spherical, rod shaped, prismatic and cubic) synthesised using a common chemical surfactant (CTAB), is presented. Using fluorescence spectroscopy it is shown that all AuNPs exhibit static binding with HSA, however the shape affects both the affinity and strength of the binding. Rod shaped nanoparticles were found to have the highest binding strength and affinity. Conversely, shapes with large flat planar surfaces such as prisms and cubes were shown to have reduced accessibility to the site of the fluorophore within the structure of HSA. The differences observed help to provide a better understanding of the effect of shape on AuNP-protein interactions - knowledge which may be applied to the development of AuNPs for future biological applications.


Assuntos
Ouro/química , Nanopartículas Metálicas/química , Albumina Sérica Humana/química , Humanos , Espectrometria de Fluorescência , Tensoativos/química
3.
Biomed Res Int ; 2018: 9472939, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29850590

RESUMO

Diethylnitrosamine (DEN) induces hepatocarcinogenesis, increasing mitotic hepatocytes and leading to chronic inflammation. In addition, type 1 diabetes mellitus (T1DM) is also characterized by a proinflammatory state and by requiring insulin exogenous treatment. Given the association of diabetes, insulin treatment, and cell proliferation, our specific goal was to determine whether the liver in the diabetic state presents a greater response to DEN-induced cell cycle alteration, which is essential for the malignant transformation. Male C57BL/6 mice (four-week-old) were divided into 4 groups: C, C + DEN, T1DM, and T1DM + DEN. Mice were euthanized ten weeks after DEN injection. DEN per se produced an increase in liver lipid peroxidation levels. Besides, in T1DM + DEN, we found a greater increase in the proliferation index, in comparison with C + DEN. These results are in agreement with the increased expression observed in cell cycle progression markers: cyclin D1 and E1. In addition, a proapoptotic factor, such as activated caspase-3, evidenced a decrease in T1DM + DEN, while the Vascular Endothelial Growth Factor (VEGF) and the protooncogene p53 showed a higher increase with respect to C + DEN. Overall, the results allow us to highlight a major DEN response in T1DM, which may explain in part the greater predisposition to the development of hepatocarcinoma (HCC) during the diabetic state.


Assuntos
Carcinoma Hepatocelular/patologia , Proliferação de Células/efeitos dos fármacos , Diabetes Mellitus Experimental/patologia , Dietilnitrosamina/toxicidade , Neoplasias Hepáticas/patologia , Fígado , Animais , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Tipo 1 , Insulinas/uso terapêutico , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL
4.
J Clin Pharm Ther ; 41(1): 106-7, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26792111

RESUMO

WHAT IS KNOWN AND OBJECTIVES: The occurrence of dysgraphia after sertraline intake has never been reported. The objective was to describe a case of this adverse drug reaction and present a review of similar cases held in international databases with a discussion of the possible pharmacological mechanisms. CASE SUMMARY: We observed a 60-year-old man who experienced resting tremors, dyskinesia and dysgraphia 2 months after a stepwise increase in sertraline dosing from 50 to 200 mg/day. WHAT IS NEW AND CONCLUSION: Dysgraphia is a possible adverse drug reaction to sertraline, and we suggest that inhibition of extrapyramidal dopaminergic activity might be the pharmacological mechanism.


Assuntos
Agrafia/induzido quimicamente , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Sertralina/efeitos adversos , Sistemas de Notificação de Reações Adversas a Medicamentos , Bases de Dados Factuais , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores Seletivos de Recaptação de Serotonina/administração & dosagem , Sertralina/administração & dosagem
5.
J Clin Pharm Ther ; 40(3): 342-4, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25726970

RESUMO

WHAT IS KNOWN AND OBJECTIVES: To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international databases. CASE SUMMARY: A few hours after the subcutaneous administration of this drug at therapeutic dose, the patient experienced throbbing headache. Rechallenge on two other separate occasions separated by several days produced the same effect although with reduced intensity when the dose was lowered. The Naranjo Algorithm indicated a 'certain' relationship. WHAT IS NEW AND CONCLUSION: We report a case of throbbing headache associated with the use of enoxaparin; with the increasing use of enoxaparin, physicians who prescribe this drug should be aware of this potential ADR. We suggest that it is a heparin class-effect, and therefore, a more general caution is also appropriate.


Assuntos
Anticoagulantes/efeitos adversos , Enoxaparina/efeitos adversos , Cefaleia/induzido quimicamente , Anticoagulantes/administração & dosagem , Bases de Dados Factuais , Relação Dose-Resposta a Droga , Enoxaparina/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Farmacovigilância
6.
Eur J Clin Microbiol Infect Dis ; 34(1): 169-175, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25107624

RESUMO

Patients with brain injury are prone to bacterial colonisations because of mechanical ventilation during intensive care and the long-term retention of tracheostomical tubes during rehabilitation. Reduced levels of isolation, typical of rehabilitation, could also contribute to propagate colonisations. We evaluated the presence of bacteria through different stages of healthcare, their antibiotic resistances and their clinical impact in a rehabilitation setting. This retrospective study included all tracheostomised patients referred to the paediatric brain injury unit of the Scientific Institute IRCCS E. Medea (Italy) over a six-year period. Data were collected from antibiograms regarding the presence of bacterial species and antibiotic resistances; clinical data were collected from medical records. Antibiograms revealed bacteria and antibiotic resistances typical of intensive care, while prevalence patterns were characteristic for each species (P. aeruginosa and S. aureus prevailing in the acute setting, K. pneumoniae, A. baumannii and others in rehabilitation). Despite very frequent antibiotic resistances, consistent with Italian averages, we observed a limited clinical impact for these colonisations. We analysed risk factors correlating to the development of respiratory symptoms and found a role for the acute clinical course after brain injury (having undergone neurosurgery; duration of intensive care stay) as well as for rehabilitation (duration of coma). Our data suggest that, in a long-term perspective, an appropriate balance is yet to be found between patient isolation and social interactions, to control respiratory colonisations and antibiotic resistances without compromising rehabilitation. They also suggest that regular containment measures should be complemented by thorough training to non-medic personnel and parents alike.


Assuntos
Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Infecções Bacterianas/epidemiologia , Portador Sadio/epidemiologia , Farmacorresistência Bacteriana , Traqueostomia/efeitos adversos , Adolescente , Bactérias/isolamento & purificação , Infecções Bacterianas/microbiologia , Portador Sadio/microbiologia , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Humanos , Lactente , Itália/epidemiologia , Masculino , Testes de Sensibilidade Microbiana , Prevalência , Centros de Reabilitação , Estudos Retrospectivos , Fatores de Risco , Adulto Jovem
7.
Pharmacogenomics J ; 15(3): 284-7, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25287071

RESUMO

Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/genética , Variação Genética/genética , Vacinação/efeitos adversos , Vacinas/efeitos adversos , Humanos , Farmacogenética/métodos , Risco
8.
Eur J Clin Microbiol Infect Dis ; 33(9): 1519-24, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24756210

RESUMO

Bacterial meningitis is an important source of mortality and morbidity worldwide. Data exist on specific vaccines against Streptococcus pneumoniae and Neisseria meningitidis indicating that they reduce the incidence of meningitis, yet comprehensive information on the trend of bacterial meningitis is still lacking. We analysed the Kids' Inpatient Database and the National Inpatient Database considering all bacterial meningitides in the United States, excluding cases of tuberculosis and sexually transmitted diseases. We analysed the trend of meningitis incidence from 1993 to 2011 and in specific age groups before and after the introduction of the pneumococcal conjugate vaccine 7 (PCV-7) and the meningococcal conjugate vaccine 4 (MCV-4). Moreover, we analysed the prevalence of aetiological agents to assess their changes. We estimated 295,706 cases of meningitis having occurred in the United States and a reduction of the discharge rate of 21 %. We observed a significant reduction in cases of meningitis in children and elderly patients following the introduction of the PCV-7. We also found a reduction in subjects aged 10-14 years, an age span consistent with the introduction of MCV-4, although further analyses based on serotypes data are required to confirm this observation. By contrast, we observed an increased prevalence of cases of staphylococcal and streptococcal meningitides. The introduction of PCV-7 has reduced the incidence and changed significantly the aetiology of bacterial meningitis in the United States during the last two decades.


Assuntos
Hospitalização , Meningites Bacterianas/epidemiologia , Adolescente , Adulto , Idoso , Bactérias/classificação , Bactérias/isolamento & purificação , Criança , Pré-Escolar , Feminino , Vacina Pneumocócica Conjugada Heptavalente , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Meningites Bacterianas/etiologia , Vacinas Meningocócicas/administração & dosagem , Pessoa de Meia-Idade , Vacinas Pneumocócicas/administração & dosagem , Prevalência , Estados Unidos/epidemiologia , Adulto Jovem
9.
J Clin Pharm Ther ; 38(6): 524-5, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23889005

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Chronic constipation is very frequent in the general population. Although usually considered banal, this disorder has considerable personal, social and healthcare impact. Several studies have shown that the psychological impact exceeds that caused by rheumatoid arthritis or haemodialysis. Recently, prucalopride, a highly selective 5-HT4 receptor agonist has been shown to improve the symptoms of chronic constipation and to have a beneficial effect on social and healthcare impact. The drug was approved by the European Medicine Agency, in 2009 at a dose of 2 mg/day, 'for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief'. Neurological side effects or psychiatric disorders have not been reported previously with prucalopride. We present the case of a 61-year-old woman, who developed such adverse effects when given prucalopride for the treatment for chronic constipation. CASE SUMMARY: A few hours after oral administration of this drug at therapeutic dose (2 mg/day), the patient experienced life-threatening neurological effects that included visual hallucination, loss of balance and memory, disorientation, exhaustion and suicidal ideation. Analysis with the Naranjo algorithm indicated a 'possible' relationship between prucalopride and these disorders. WHAT IS NEW AND CONCLUSION: This is the first report of prucalopride-induced neurological side effects and psychiatric disorders with prucalopride. The absence of other similar reports suggests that prucalopride rarely causes these adverse effects.


Assuntos
Benzofuranos/efeitos adversos , Transtornos Mentais/induzido quimicamente , Doenças do Sistema Nervoso/induzido quimicamente , Agonistas do Receptor 5-HT4 de Serotonina/efeitos adversos , Benzofuranos/uso terapêutico , Doença Crônica , Constipação Intestinal/tratamento farmacológico , Feminino , Alucinações/induzido quimicamente , Alucinações/psicologia , Humanos , Transtornos da Memória/induzido quimicamente , Transtornos da Memória/psicologia , Transtornos Mentais/psicologia , Pessoa de Meia-Idade , Doenças do Sistema Nervoso/psicologia , Orientação/efeitos dos fármacos , Equilíbrio Postural/efeitos dos fármacos , Serotonina/fisiologia , Agonistas do Receptor 5-HT4 de Serotonina/uso terapêutico , Ideação Suicida
10.
J Clin Pharm Ther ; 38(2): 169-71, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23194101

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Rheumatoid arthritis is an autoimmune disorder characterized by persistent synovitis and systemic inflammation. Genetic factors account for approximately 50% of cases of rheumatoid arthritis and environmental factors include smoking. Urinary incontinence may occur as a medication adverse effect. We present the first report of a case of hydroxychloroquine-induced urinary incontinence in rheumatoid arthritis. DETAILS OF THE CASE: A 71-year-old female with a history of rheumatoid arthritis developed urinary incontinence as an adverse drug reaction to hydroxychloroquine administered at therapeutic doses. Urinary incontinence remitted with drug withdrawal and reappeared on rechallenge. The Naranjo's algorithm indicated that hydroxychloroquine was a probable cause of this adverse drug reaction. The likely mechanism of this adverse drug is a direct action of the quinolone on the urinary system. WHAT IS NEW AND CONCLUSION: This is the first report of hydroxychloroquine-induced urinary incontinence. The absence of previous reports suggest that the drug rarely causes this adverse effect. Methotrexate is most often used as first-line treatment, and several other drugs are now available to act as Disease-Modifying Antirheumatic Drugs (DMARDs). These drugs may be used alone or combined with methotrexate, most often to increase efficacy and reduce toxicity. The introduction of new biological agents, such as abatacept, rituximab, tocilizumab and inhibitors of tumour necrosis factor, has opened new therapeutic perspectives but are restricted by high costs and risk of infections. Thus, antimalarial drugs, especially the quinolones chloroquine (CQ) and hydroxychloroquine (HCQ), are still in use, and the latter is very efficacious. An advantage of HCQ is its low toxicity compared with other antimalarial drugs. Common side-effects of HCQ and the other antimalarial drugs include gastrointestinal effects such as nausea and vomiting, as well as skin rashes and headache, whereas their most common and severe side-effect is retinopathy. No case of urinopathy has been reported previously with HCQ.


Assuntos
Antirreumáticos/efeitos adversos , Antirreumáticos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Hidroxicloroquina/efeitos adversos , Hidroxicloroquina/uso terapêutico , Incontinência Urinária/induzido quimicamente , Fatores Etários , Idoso , Feminino , Humanos
11.
Life Sci ; 68(12): 1417-26, 2001 Feb 09.
Artigo em Inglês | MEDLINE | ID: mdl-11388693

RESUMO

The present work analyzes the expression of insulin receptors and theirs related intracellular signaling molecules in partially hepatectomized-diabetic rats. Insulin binding through Scatchard analysis was studied using isolated hepatocytes of Control (Sham-operated), Hepatectomized, Diabetic and Diabetic-Hepatectomized male Wistar rats. In a set of in vivo experiments, the levels of alpha subunit of the insulin receptor, the insulin receptor substrate 1 (IRS-1) and the phosphatidylinositol 3-kinase (PI3K) were determined. [3H]-thymidine incorporation into DNA 24 or 48 h after surgery was assessed in all the experimental groups. Scatchard analysis showed that insulin receptor number was increased in diabetic and in hepatectomized rats in the same extent (64%, with respect to Controls). Diabetic-hepatectomized rats showed a dramatic increase of the receptor concentration (400%) and on the affinity constant (532%). Besides, the insulin receptor expression was increased in the treated groups, being the higher values those of the diabetic-hepatectomized rats. IRS-1 and PI3K showed similar increases. DNA synthesis was not impaired by the diabetes state. In conclusion, increased expression of IR and IRS-1 leads to increased association of PI3K in vivo in diabetic regenerating rats. The enhancement of this pathway may reveal an insulin hyperresponsiveness in these animals.


Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Hepatectomia , Insulina/farmacologia , Regeneração Hepática , Animais , Sítios de Ligação , Ligação Competitiva , Contagem de Células , Sobrevivência Celular , DNA/biossíntese , Diabetes Mellitus Experimental/metabolismo , Hepatócitos/citologia , Hepatócitos/metabolismo , Técnicas In Vitro , Insulina/metabolismo , Proteínas Substratos do Receptor de Insulina , Masculino , Fosfatidilinositol 3-Quinases/metabolismo , Fosfoproteínas/metabolismo , Ratos , Ratos Wistar , Receptor de Insulina/metabolismo
12.
Biochem Pharmacol ; 61(12): 1587-93, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11377389

RESUMO

Polyamines are key factors in macromolecule synthesis during liver regeneration. It has been postulated that interferon-alpha (IFNalpha) decreases putrescine levels in regenerating liver by inhibiting ornithine decarboxylase (ODC) activity, the main enzyme in polyamine biosynthesis. In the present study, we analysed the effects of a pharmacological dose of IFNalpha on polyamine and ODC levels during the regenerative process following partial hepatectomy in rats. Synthesis of ODC by isolated hepatocytes from IFN-treated rats with regenerating livers was also assessed. Furthermore, we investigated the effect of IFNalpha-2b on DNA and total protein synthesis in 24-hr regenerating livers. No effect on DNA synthesis was observed at the dose of IFNalpha-2b used, but total protein synthesis decreased significantly in IFNalpha-2b-treated rats undergoing liver regeneration (7.0 +/- 2.0 and 12.1 +/- 1.7%. min(-1) in hepatectomized rats treated with IFNalpha-2b and saline, respectively). ODC levels were also reduced significantly (by 50%) in hepatectomized rats treated with IFNalpha-2b versus saline. In parallel with the ODC decrease, the concentrations of putrescine and spermidine (63 +/- 25 vs 101 +/- 15 nmol/g liver and 1.08 +/- 0.35 vs 2.14 +/- 0.22 micromol/g liver, respectively, in IFNalpha-2b- and saline-treated hepatectomized rats) showed similar, significant diminutions. Moreover, the incorporation of [35S]methionine into ODC was decreased dramatically in isolated hepatocytes from IFNalpha-2b-treated hepatectomized rats 12 hr after surgery. In conclusion, the protein synthesis rate in regenerating liver was impaired by therapeutic doses of IFNalpha-2b. In addition, the results presented in this study suggest that IFNalpha-2b negatively regulates ODC synthesis, causing a reduction in polyamine levels during liver regeneration.


Assuntos
DNA/efeitos dos fármacos , Hepatócitos/efeitos dos fármacos , Interferon-alfa/farmacologia , Regeneração Hepática/efeitos dos fármacos , Ornitina Descarboxilase/metabolismo , Animais , DNA/biossíntese , Regulação para Baixo , Hepatócitos/enzimologia , Interferon alfa-2 , Masculino , Ornitina Descarboxilase/efeitos dos fármacos , Poliaminas/metabolismo , Ratos , Ratos Wistar , Proteínas Recombinantes , Timidina/metabolismo , Trítio
13.
Exp Gerontol ; 36(2): 255-65, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11226741

RESUMO

Age-associated differences in the response of the initiation and promotion of hepatocellular carcinogenesis in the rat were analyzed. Male Wistar rats 5 and 18 months-old were used throughout. They underwent an experimental design of multistage model of hepatocarcinogenesis: hepatic cells were initiated with the complete carcinogen Aflatoxin B1 (0.5mg/Kg b.w.) and the promotion was performed through a combined treatment of proliferation (partial hepatectomy, 65%) and administration of the tumorigenic promoter phenobarbital (0.1% in drinking water for 21 days). After the treatment, rats were sacrificed and the following parameters were determined: activity and subunit composition of the glutathione S-transferase enzyme system, the number of liver preneoplastic foci and the proliferation cell index. The combined treatment (initiation + promotion) lowered the expression of the mu class GST (rGST M1, rGST M2). The inhibition in rGST M2 in old animals (which in basal conditions had already been lower) was significant. On the other hand, the treatment increased the alpha class GST (rGST A, rGST A3). The number of preneoplastic foci was higher in old rats (number of foci/cm(2): 6.9+/-0.3 vs 3.9+/-0.3 in young rats, p< 0.05). The proliferation cell index did not show age-related differences. Because rGST M2 deficiency coexisted with induced expression of alpha class, the livers would be resistant to some toxic insults, being selectively sensitive to potentially genotoxic substances for which M2 is an essential detoxification pathway. The transition to a rGST M2-deficient phenotype during aging could induce higher responsiveness to genotoxic effects, and might favor the likelihood of further progression, indicating a higher susceptibility of aged animals to the development of carcinogenesis.


Assuntos
Envelhecimento/metabolismo , Glutationa Transferase/metabolismo , Neoplasias Hepáticas Experimentais/enzimologia , Aflatoxina B1/toxicidade , Animais , Carcinógenos/toxicidade , Glutationa Transferase/química , Glutationa Transferase/classificação , Imuno-Histoquímica , Neoplasias Hepáticas Experimentais/etiologia , Masculino , Fenobarbital/toxicidade , Lesões Pré-Cancerosas/enzimologia , Lesões Pré-Cancerosas/etiologia , Antígeno Nuclear de Célula em Proliferação/metabolismo , Subunidades Proteicas , Ratos , Ratos Wistar
14.
Medicina (B Aires) ; 61(5 Pt 2): 666-9, 2001.
Artigo em Espanhol | MEDLINE | ID: mdl-12058585

RESUMO

In order to know whether IFN alpha prevents in vivo oncogenesis in the very-early-stage cancer cells, we evaluated the action of IFN alpha-2b on preneoplastic foci in rats. Animals were divided into six groups: subjected to an initiation-promotion model of cancer development (G1), treated with IFN alpha-2b during: a) initiation-promotion (G2), b) initiation (G3), promotion (G4); subjected only to an initiation stage (G5) and treated with IFN alpha-2b during this period (G6). The number and area of rGST P-positive foci were reduced and the Apoptotic index was increased in G2, 3 and 6. Bcl-2 and Bcl-XL protein levels were decreased in IFN alpha-2b-treated rats. Increased levels of mitochondrial Bax protein were observed in G2, 3 and 6. In conclusion, preneoplastic hepatocytes in the IFN alpha-2b-treated rats undergo programmed cell death as a result of a significant increase of Bax and its translocation to the mitochondria.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Interferon-alfa/farmacologia , Neoplasias Hepáticas/prevenção & controle , Lesões Pré-Cancerosas/prevenção & controle , Animais , Apoptose/fisiologia , Western Blotting , Interferon alfa-2 , Fígado/enzimologia , Fígado/patologia , Masculino , Proteínas Proto-Oncogênicas/análise , Ratos , Ratos Wistar , Proteínas Recombinantes
15.
Medicina [B Aires] ; 61(5 Pt 2): 666-9, 2001.
Artigo em Espanhol | BINACIS | ID: bin-39296

RESUMO

In order to know whether IFN alpha prevents in vivo oncogenesis in the very-early-stage cancer cells, we evaluated the action of IFN alpha-2b on preneoplastic foci in rats. Animals were divided into six groups: subjected to an initiation-promotion model of cancer development (G1), treated with IFN alpha-2b during: a) initiation-promotion (G2), b) initiation (G3), promotion (G4); subjected only to an initiation stage (G5) and treated with IFN alpha-2b during this period (G6). The number and area of rGST P-positive foci were reduced and the Apoptotic index was increased in G2, 3 and 6. Bcl-2 and Bcl-XL protein levels were decreased in IFN alpha-2b-treated rats. Increased levels of mitochondrial Bax protein were observed in G2, 3 and 6. In conclusion, preneoplastic hepatocytes in the IFN alpha-2b-treated rats undergo programmed cell death as a result of a significant increase of Bax and its translocation to the mitochondria.

16.
J Hepatol ; 32(5): 798-804, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10845667

RESUMO

BACKGROUND/AIMS: Clarification of the role of lipid peroxidation in the onset of liver proliferation has been hampered by the fact that both higher and lower lipid peroxidation have been reported after two-thirds partial hepatectomy. Recently, it has been shown that nitric oxide might be involved in the control of early responses after partial hepatectomy. We analysed the possible involvement of nitric oxide production in lipid peroxidation levels during liver regeneration. METHODS: Sham-operated, hepatectomised and sham and hepatectomised rats pretreated with two inhibitors of oxide nitric synthesis (aminoguanidine or N(G)-monomethyl-L-arginine) were used throughout. Animals were killed at 1, 3, 5 and 15 h after surgery. Cytosolic superoxide dismutase and microsomal-lysosomal catalase activities were measured. Lipid peroxidation levels were measured as thiobarbituric acid-reactive substances and conjugated dienes. Cytosolic nitrate (a stable metabolic product of nitric oxide) was enzymatically determined. Inducible-type nitric oxide synthase (iNOS) was analysed in hepatic cytosol by immunoblotting. DNA synthesis 24 and 48 h after surgery was assessed by [3H]thymidine incorporation. RESULTS: Increased lipid peroxidation was found in total homogenate, cytosol and microsomes. The hepatic cytosolic content of nitrates increased, reaching the highest values at 5 h posthepatectomy. Aminoguanidine or N(G)-monomethyl-L-arginine pretreatment blocked the rise of nitric oxide production and lipid peroxidation levels and decreased the DNA synthesis. The increase in hepatic iNOS protein expression at 5 h after partial hepatectomy disappeared with aminoguanidine pretreatment. CONCLUSIONS: Our experiments suggest that nitric oxide plays a role in the proliferation mechanism, although it is responsible, at least in part, for the enhanced lipid peroxidation.


Assuntos
Peroxidação de Lipídeos/fisiologia , Regeneração Hepática , Fígado/fisiologia , Óxido Nítrico/fisiologia , Animais , Divisão Celular , Fígado/patologia , Masculino , Ratos , Ratos Wistar
17.
Toxicol Lett ; 104(3): 211-9, 1999 Feb 22.
Artigo em Inglês | MEDLINE | ID: mdl-10079056

RESUMO

In order to elucidate if the inhibition mechanisms of Aluminum (Al) on intestinal calcium flux involve some possible action on calbindin-D9k, a series of in vivo and in vitro experiments were carried out in normal and in streptozotocin-induced diabetic male rats. The dose-response curves obtained from the in vitro studies indicate that, in the diabetic group (which has a lower content of calbindin-D9k), the effect of Al on JCa(ms) has a small dependence on rising Al concentration (0-10 microM). The parameters obtained from those curves: Emax (maximum reduction percentage of JCa(ms)) and ED50 (Al concentration that produces half of the highest inhibition) were significantly diminished in this group compared to control. Both s.c. injections of calcitriol (D3) at doses of 0.08 and 0.40 microg/kg body wt. per day and insulin (10 IU/kg body wt. per day), increase the inhibitory effect of Al to levels that did not differ from controls. In vivo gavage of 60 mg/kg body wt. per day of aluminum chloride for 1 week reveals that the degree of reduction of intestinal CaBP9k by Al is directly correlated to duodenal content of this protein (r2 = 0.683, P = 0.022).


Assuntos
Alumínio/toxicidade , Cálcio/metabolismo , Diabetes Mellitus Experimental/metabolismo , Duodeno/efeitos dos fármacos , Duodeno/metabolismo , Proteína G de Ligação ao Cálcio S100/efeitos dos fármacos , Proteína G de Ligação ao Cálcio S100/metabolismo , Animais , Transporte Biológico/efeitos dos fármacos , Calbindinas , Relação Dose-Resposta a Droga , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Masculino , Ratos , Ratos Wistar , Proteína G de Ligação ao Cálcio S100/sangue , Membrana Serosa/efeitos dos fármacos , Membrana Serosa/metabolismo
18.
J Hepatol ; 28(4): 700-8, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9566840

RESUMO

BACKGROUND/AIMS: The mechanism by which many cytochrome P450 (CYP) isozymes decrease during liver regeneration is unclear. Peptides and growth factors are thought to be involved. Putrescine, the first polyamine synthesised by ornithine decarboxylase, peaks early following partial hepatectomy and is known to play an essential role in hepatic regeneration. Gamma amino butyric acid was reported as a physiologic inhibitor of ornithine decarboxylase. In this work we studied the possible involvement of putrescine in the CYP reduction during liver regeneration. METHODS: Hepatectomised, putrescine-treated sham, and GABA-treated hepatectomised rats were used throughout. Total hepatic cytochrome P450, o-dealkylase activities (CYP1A1 and CYP2B1/2), nifedipine oxidase activity (CYP3A4), and Western blot assays of their respective apoproteins were analysed in liver microsomes. Putrescine levels in hepatic tissue were also measured. RESULTS: Partial hepatectomy and putrescine treatment induced a significant diminution in total CYP (50% and 30% of sham-operated rats, respectively). Gamma amino butyric acid treatment prevented this decrease in partially hepatectomised rats. Nifedipine oxidase activity of partially hepatectomised and putrescine-treated rats significantly decreased to 43% and 60% of that in sham-operated rats, respectively. Again, gamma amino butyric acid prevented the diminution in partially hepatectomised rats. No significant changes were observed in o-dealkylase activities. CONCLUSIONS: These results show that inducible CYP1A1 and CYP2B1/2, which are important in carcinogen metabolisation, are preserved after partial hepatectomy. However, constitutive CYP3A4, which represents 50% of total CYP and metabolises drugs like nifedipine, warfarin, acetaminophen, cyclosporin and FK-506, is reduced during liver regeneration. Our experiments suggest that endogenous putrescine is, at least, partly responsible for this decrease.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Regeneração Hepática/efeitos dos fármacos , Oxigenases de Função Mista/metabolismo , Putrescina/farmacologia , Animais , Apoproteínas/metabolismo , Western Blotting , Citocromo P-450 CYP1A1/metabolismo , Citocromo P-450 CYP2B1/metabolismo , Citocromo P-450 CYP3A , DNA/biossíntese , Hepatectomia , Isoenzimas/metabolismo , Masculino , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/metabolismo , Ratos , Ratos Wistar , Ácido gama-Aminobutírico/farmacologia
19.
Mech Ageing Dev ; 91(1): 55-64, 1996 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-8910260

RESUMO

The aim of the present study was to measure protein synthesis in regenerating liver and to evaluate the impact of malnutrition in young and old rats. Two groups of male Wistar rats were used: young rats (4 months old) and old rats (18 months old). The rats were allocated to malnutrition or ordinary food intake for 1 week. Half of each group was sham-operated and the other was partially hepatectomized 2 days before the end of diet manipulation. Hepatic protein synthesis was significantly increased in all hepatectomized groups compared with their respective sham group: young well-nourished hepatectomized rats, 44%; young malnourished hepatectomized rats, 55%; old well-nourished hepatectomized rats, 47%; and old malnourished hepatectomized rats only 21%. Hepatic DNA content was unchanged in all groups and liver RNA content was higher in young malnourished hepatectomized rats (21%, P < 0.05). Serum total amino acid concentration did not change in young well-nourished hepatectomized and young malnourished hepatectomized rats. This value did not show significant changes between old well-nourished hepatectomized and old well-nourished sham, but it increased 14% (P < 0.05) in old malnourished hepatectomized. It was concluded that (a) regeneration is not impaired by malnutrition in young rats and may even be better than in rats eating a normal diet, and (b) the deleterious effect of aging is revealed once old animals are exposed to malnutrition. It is manifested in the decreased rate in hepatic protein synthesis observed in old malnourished hepatectomized rats and in the augmentation of total serum amino acid concentration, where the hypercatabolism induced by hepatectomy is significantly greater.


Assuntos
Aminoácidos/metabolismo , Fígado/metabolismo , Distúrbios Nutricionais/metabolismo , Proteínas/metabolismo , Regeneração/fisiologia , Fatores Etários , Animais , Masculino , Ratos , Ratos Wistar
20.
Toxicol Lett ; 85(3): 165-71, 1996 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8644129

RESUMO

Everted sacs of distinct segments of small intestine from male and female rats were incubated with 2 microM of aluminum (Al). In duodenum, Al significantly diminished calcium flux (JCams) in cycling females (31%, P < 0.01) and in males (17%, P < 0.05). Incubation under anaerobic conditions nullified the inhibition of Al on JCams both in male and in female duodenal sacs. Jejunal and ileal JCams measured under aerobic conditions were not modified by the presence of Al in mucosal fluid compared to Al-free controls, neither in males nor in cycling females. In ovariectomized female rats treated with estrogen the studies of dose-response curves showed that the sensitivity to the effect of Al on JCams was raised (the dose that produced half maximum response diminished) with increasing 17 beta-estradiol serum levels, without changes in the maximum response. In castrated male rats injected with testosterone, the effect of Al on duodenal JCams was found to be independent of testosterone levels. In summary, our results demonstrated that the Al inhibition on duodenal JCams was influenced by sexual hormone levels in females but was independent of them in males.


Assuntos
Alumínio/toxicidade , Cálcio/metabolismo , Estradiol/sangue , Intestino Delgado/efeitos dos fármacos , Caracteres Sexuais , Testosterona/sangue , Fosfatase Alcalina/metabolismo , Análise de Variância , Animais , Transporte Biológico/efeitos dos fármacos , Relação Dose-Resposta a Droga , Duodeno/efeitos dos fármacos , Duodeno/metabolismo , Feminino , Glucose/metabolismo , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/enzimologia , Mucosa Intestinal/metabolismo , Intestino Delgado/metabolismo , Jejuno/efeitos dos fármacos , Jejuno/metabolismo , Masculino , Radioimunoensaio , Ratos , Ratos Wistar , Distribuição Tecidual , Água/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...